Company Directory / research
PrivateFor profitresearchFujisawa, Japan
Scohia Pharma
Scohia Pharma is a biotech venture that will have both substantial research and development resources.
- Founded
- 2017 9 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $10B as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
9 years old.
Reach
Website ranked #4,198,046 in the world for traffic, about 2k visits a month.
What it does
BiotechnologyHealth CareHealth DiagnosticsProduct Research
Funding, as listed
$10B currency not stated
- Rounds1
- LatestCorporate round, Mar 2017
- Investors3
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Scohia Pharma, field by field. Contact details are held but never shown.
The company
- Name
- Scohia Pharma
- Type
- For profit
- Status
- Private
- Founded
- 2017
- Founders
- Yoichi Okumura
- Industry
- research
- Categories
- Biotechnology, Health Care, Health Diagnostics, Product Research
Where
- City
- Fujisawa
- Country
- Japan
- Markets
- Asia-Pacific (APAC)
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #4,198,046
- Monthly web visits
- 2,396
Funding, as listed
- Total
- 10,000,000,000 (currency not stated)
- Rounds
- 1
- Latest round
- Corporate round
- Latest round date
- Mar 2017
- Investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Scohia Pharma may be growing as it is mentioned in multiple news articles related to the biotechnology and health care industries. The company is listed among key companies in reports predicting significant growth in markets such as the primary sclerosing cholangitis market, which is expected to grow at a CAGR of 17.2% during the study period of 2019-2032, and the complement 3 glomerulopathy market, which is anticipated to see an upsurge in growth by 2023. Additionally, Scohia Pharma is noted in the context of the chronic kidney disease clinical trial pipeline, indicating active involvement in research and development within its industry.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Japan.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 32,492 companies in Japan and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.